SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014236
Filing Date
2020-12-08
Accepted
2020-12-08 07:07:01
Documents
14
Period of Report
2020-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20201208x8k.htm   iXBRL 8-K 44933
2 EX-99.1 axsm-20201208xex99d1.htm EX-99.1 41824
3 GRAPHIC axsm-20201208xex99d1001.jpg GRAPHIC 4928
  Complete submission text file 0001558370-20-014236.txt   225272

Data Files

Seq Description Document Type Size
4 EX-101.SCH axsm-20201208.xsd EX-101.SCH 3250
5 EX-101.LAB axsm-20201208_lab.xml EX-101.LAB 16159
6 EX-101.PRE axsm-20201208_pre.xml EX-101.PRE 10965
7 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20201208x8k_htm.xml XML 4869
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 201374393
SIC: 2834 Pharmaceutical Preparations